Moleculin Biotech, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| Operating income | -$25.1 | -$26.6 | -$29.6 | -$30.6 | -$23.0 |
| Net income | -$33.6 | -$26.0 | -$29.8 | -$29.0 | -$15.9 |
| Cash Flow Statement | |||||
| Free cash flow | -$22.7 | -$23.9 | -$23.7 | -$27.7 | -$19.0 |
Shares outstanding 19.5M · Free float 81.9%
Annual filing data through FY ended December 31, 2025; float as of October 3, 2026.